Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 503,800 shares, an increase of 11.5% from the December 31st total of 452,000 shares. Based on an average trading volume of 136,600 shares, the short-interest ratio is currently 3.7 days.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded down $2.07 on Tuesday, hitting $123.02. The company's stock had a trading volume of 58,408 shares, compared to its average volume of 146,493. The stock has a 50 day moving average of $126.90 and a 200-day moving average of $127.39. The company has a market capitalization of $2.23 billion, a price-to-earnings ratio of 28.21, a price-to-earnings-growth ratio of 1.62 and a beta of 1.00. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.03 earnings per share. Sell-side analysts expect that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on ADUS shares. Macquarie restated an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Friday, January 24th. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 target price for the company. Stephens increased their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Finally, JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 price target for the company. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of "Buy" and an average price target of $134.22.

Insider Activity at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock valued at $4,930,750 in the last ninety days. Company insiders own 4.60% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quarry LP purchased a new stake in shares of Addus HomeCare during the 3rd quarter valued at $28,000. Farther Finance Advisors LLC increased its stake in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the last quarter. KBC Group NV raised its holdings in shares of Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company's stock valued at $124,000 after purchasing an additional 191 shares in the last quarter. Finally, Assetmark Inc. grew its holdings in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company's stock worth $156,000 after purchasing an additional 121 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.